10X Genomics Inc
NASDAQ:TXG
10X Genomics Inc
NASDAQ:TXG
Price:
27.48 USD
4.53%
Market Closed
Updated:
May 5, 2024
10X Genomics Inc
Cash from Financing Activities
|
10X Genomics Inc
Cash from Financing Activities Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
10X Genomics Inc
NASDAQ:TXG
|
Cash from Financing Activities
$18.7m
|
CAGR 3-Years
-67%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash from Financing Activities
-$3.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Danaher Corp
NYSE:DHR
|
Cash from Financing Activities
-$144m
|
CAGR 3-Years
67%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
17%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Cash from Financing Activities
-$859.6m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-13%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Cash from Financing Activities
-$1.2B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-8%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cash from Financing Activities
-$382m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
See Also
What is 10X Genomics Inc's Cash from Financing Activities?
Cash from Financing Activities
18.7m
USD
18.7m
USD
Based on the financial report for Mar 31, 2024, 10X Genomics Inc's Cash from Financing Activities amounts to 18.7m USD.
What is 10X Genomics Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-67%
-67%
Over the last year, the Cash from Financing Activities growth was 87%. The average annual Cash from Financing Activities growth rates for 10X Genomics Inc have been -67% over the past three years .
You don't have any saved screeners yet
